410529-86-1 Usage
General Description
Tert-butyl ((diphenylphosphoryl)-methyl)sulfonylcarbamate is a chemical compound that is used as a reagent in organic synthesis. It is a white crystalline solid that is often used as a protecting group for organic functional groups, particularly for the protection of amines and alcohols. tert-Butyl ((diphenylphosphoryl)-methyl)sulfonylcarbamate is commonly used in the synthesis of pharmaceuticals and other organic compounds. It is stable under normal conditions and can be stored and handled safely in a laboratory setting. When used in organic reactions, it undergoes specific chemical reactions to achieve the desired transformation of the target molecule. Overall, tert-butyl ((diphenylphosphoryl)-methyl)sulfonylcarbamate plays an important role as a reagent in synthetic organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 410529-86-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,1,0,5,2 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 410529-86:
(8*4)+(7*1)+(6*0)+(5*5)+(4*2)+(3*9)+(2*8)+(1*6)=121
121 % 10 = 1
So 410529-86-1 is a valid CAS Registry Number.
410529-86-1Relevant articles and documents
Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
Agarwal, Sameer,Pethani, Jignesh P.,Shah, Hardik A.,Vyas, Vismit,Sasane, Santosh,Bhavsar, Harsh,Bandyopadhyay, Debdutta,Giri, Poonam,Viswanathan, Kasinath,Jain, Mukul R.,Sharma, Rajiv
, (2020/10/06)
NLRP3 inflammasome mediated release of interleukin-1β (IL-1β) has been implicated in various diseases, including COVID-19. In this study, rationally designed alkenyl sulfonylurea derivatives were identified as novel, potent and orally bioavailable NLRP3 i
QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column 331, (2011/04/14)
A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
